Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-01-02 @ 10:08 AM
Study NCT ID:
NCT00320658
Status:
COMPLETED
Last Update Posted:
2008-01-21
First Post:
2006-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CIR 212
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Anna Durbin, MD
Old Organization:
Center for Immunization Research, Johns Hopkins School of Public Health
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |